Nakahara M, Yokozaki H, Yasui W, Dohi K, Tahara E
First Department of Pathology, Hiroshima University School of Medicine, Japan.
Cancer Epidemiol Biomarkers Prev. 1997 Dec;6(12):1057-64.
We analyzed microsatellite instability, alterations of the polyadenine tract in TGF-beta RII (transforming growth factor beta type II receptor gene), and mutations of hMSH2 and hMLH1 in 32 patients with familial colorectal cancer (29 kindreds) fulfilling the clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC), defined at the 34th Annual Meeting of Japanese Society for Cancer of the Colon and Rectum (Tokushima, Japan, 1991), including five kindreds fulfilling the Amsterdam criteria. Eighteen of 32 (56%) cases were replication error positive (RER+) at two or more microsatellite loci analyzed. The clinicopathological characteristics of RER+ cases corresponded well with those reported previously. Eleven of 18 RER+ cases showed RER+ at most of the microsatellite loci examined. Among these 11 cases (10 kindreds), 3 kindreds fulfilled the Amsterdam criteria and 7 kindreds did not. For these 10 kindreds, germ-line mutations in hMSH2 and hMLH1 were detected for 6 kindreds by PCR-SSCP analysis and direct sequencing. Only two of these six fulfilled the Amsterdam criteria; more than one germ-line mutation was detected in hMSH2 and/or hMLH1. Specifically, two point mutations of hMSH2 were detected in two kindreds, one point mutation of both hMSH2 and hMLH1 was detected in one kindred, two point mutations of hMSH2 and one point mutation of hMLH1 were detected in one kindred, and two point mutations of hMLH1 and one point mutation of hMSH2 were detected in one kindred. In addition, 19 of 26 (74%) cancer lesions of these 11 cases with the RER phenotype showed alterations of the polyadenine tract in TGF-beta RII. From our data, although seven kindreds did not fulfill the Amsterdam criteria, we considered them as HNPCC. Therefore, we suggest that the "Japanese criteria" have the advantage of being able to detect more HNPCC kindreds from borderline HNPCC kindreds.
我们分析了32例符合遗传性非息肉病性结直肠癌(HNPCC)临床标准的家族性结直肠癌患者(29个家系)的微卫星不稳定性、转化生长因子βⅡ型受体基因(TGF-βRII)中多聚腺苷酸序列的改变以及hMSH2和hMLH1的突变情况。这些标准是在日本结直肠癌学会第34届年会上(1991年,日本德岛)确定的,其中包括5个符合阿姆斯特丹标准的家系。在分析的32例患者中,有18例(56%)在两个或更多微卫星位点呈复制错误阳性(RER+)。RER+病例的临床病理特征与先前报道的相符。18例RER+病例中有11例在大多数检测的微卫星位点呈RER+。在这11例患者(10个家系)中,3个家系符合阿姆斯特丹标准,7个家系不符合。对于这10个家系,通过PCR-SSCP分析和直接测序在6个家系中检测到hMSH2和hMLH1的种系突变。这6个家系中只有2个符合阿姆斯特丹标准;在hMSH2和/或hMLH1中检测到不止一个种系突变。具体而言,在2个家系中检测到hMSH2的两个点突变,在1个家系中检测到hMSH2和hMLH1各一个点突变,在1个家系中检测到hMSH2的两个点突变和hMLH1的一个点突变,在1个家系中检测到hMLH1的两个点突变和hMSH2的一个点突变。此外,这11例具有RER表型的患者中,26个癌灶中有19个(74%)显示TGF-βRII中多聚腺苷酸序列的改变。根据我们的数据,尽管有7个家系不符合阿姆斯特丹标准,但我们仍将它们视为HNPCC。因此,我们认为“日本标准”具有能够从临界HNPCC家系中检测出更多HNPCC家系的优势。